scorecardresearch Skip to main content

More Life Sciences Headlines

Flagship Pioneering launches new biotech with Mass., UK offices

Quotient Therapeutics, which will have offices in Mass. and the United Kingdom, wants to develop drugs that target illnesses caused by genetic changes that occur as people age.

Vertex sickle cell drug, based on novel gene-editing technology, wins approval in UK

The go-ahead comes about two weeks before the FDA is set to determine whether CRISPR and Boston-based Vertex can market the same drug in the United States, a much larger market.

The ‘bump factor’ returns to Kendall Square

Random meetings in the compact hub help to fuel the local biotech cluster — at least on Tuesdays through Thursdays.

Theseus lays off almost three-fourths of its staff

The Cambridge biotech is the latest biopharma firm in Massachusetts to slash its workforce in a prolonged industrywide shakeout that followed years of exuberant investment and growth.

EMD Serono headquarters plans to join biopharma cluster in Boston’s Seaport

The company will join more than two dozen life sciences companies, including Vertex and Eli Lilly, in the neighborhood.

Vacancy in Boston-area lab space climbs to 10-year high

A wave of projects that launched construction a few years ago when inventory was tight are now opening into a market that suddenly has little need for them.

kara miller | the big idea

‘You can’t cure cancer when you’re sitting in traffic’: The MBTA poses a problem for Mass. competitiveness

For a state itching to herald its technological prowess, workers’ inability to quickly get to offices, labs, hospitals, and universities has become an issue of competitiveness.

Judge upholds $24 million verdict against Thermo Fisher subsidiary that discriminated against worker with anxiety

US District Court Judge Leo T. Sorokin acknowledged that the sum was “remarkable” but said he had no reason to question it.